As the novel coronavirus continues to claim dozens of lives a day in Pakistan, the only hurdle in importing the Covid-19 vaccine from Chinese state-owned company Sinopharm will be removed soon with its Phase-I trial in Karachi reaching the final stage, it emerged on Tuesday